Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content. Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

Seattle Genetics to Seek Approval For New Breast Cancer Pill After Positive Clinical Trial Results

(STAT Plus) Oct 21, 2019 - Breast cancer patients treated with a combination of medicines that included an experimental pill from Seattle Genetics (SGEN) experienced significantly delayed tumor growth and improved survival compared to standard therapy alone, according to Phase 3 clinical trial results announced Monday. Based on the results, Seattle Genetics intends to file a marketing application for the drug, called tucatinib, with the Food and Drug Administration early next year, the company said.

Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer

(Xconomy Boston) Oct 21, 2019 - Cancer therapies that harness the immune system don’t work for all patients. Verseau Therapeutics aims to bring cancer immunotherapy to more people by targeting a type of immune cell present in the vast majority of tumors and directing it to fight the disease.

Dr. Bernard Fisher, Who Revolutionized Breast Cancer Treatment, Dies at 101

(New York Times) Oct 19, 2019 - Dr. Bernard Fisher, a University of Pittsburgh surgeon whose research transformed the way breast cancer is treated, bringing an end to the routine use of the debilitating radical mastectomy, died on Wednesday in Pittsburgh. He was 101. The university announced his death on Saturday. Dr. Fisher’s research, which began in the late 1950s and spanned four decades, showed that early-stage cancers could be treated with simpler surgeries, and that treatment with chemotherapy or hormonal drugs could extend patients’ lives.

Alkermes Announces Clinical Collaboration With Fred Hutchinson Cancer Research Center for Novel Immuno-Oncology Drug Candidate ALKS 4230

(Yahoo! Finance) Oct 21, 2019 - Planned phase 2 multi-site trial to evaluate ALKS 4230 in combination with pembrolizumab in patients with advanced or recurrent head and neck squamous cell cancer.

Current And Ex Smokers May Lower Lung Cancer Risk With Exercise

(Reuters Health) Oct 18, 2019 - Men who are current or former smokers may be less likely to develop or die from lung cancer when they’re more physically fit, a recent study suggests.

pH Pharma and Immunome Enter into Collaboration and License Agreement to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates in Oncology

(Yahoo! Finance) Oct 21, 2019 - pH Pharma Co. Ltd. and Immunome, Inc. today announced the companies have entered into a collaboration and license agreement to discover unique antibody-drug conjugates (ADCs) against multiple oncology targets.

Anaesthesia for Breast Cancer Surgery Has No Influence On Risk Of Tumor Recurrence

(MedUni Vienna) Oct 21, 2019 - Study does not demonstrate long-term advantages of regional anaesthesia for breast cancer surgery and dispels misgivings about the influence of opioids on cancer recurrence.

Conference Coverage: NCCN Policy Summit September 2019

(AJMC.com Managed Markets Network) Oct 19, 2019 - Speakers at the September 12, 2019, Policy Summit of the National Comprehensive Cancer Center, held in Washington, DC, addressed what practices have learned from experience with the Oncology Care Model and what steps must occur to standardize patient reported outcomes to incorporate them into reporting.

UEG Week: Resistance to Antibiotics Used To Treat Harmful Stomach Infection Doubles In 20 Years, New Study Finds

(UEG Week Barcelona 2019) Oct 21, 2019 - Resistance to commonly-used antibiotics for treating harmful bacteria related to a variety of stomach conditions has more than doubled in 20 years, new research presented today at UEG Week Barcelona 2019 has shown.

Childhood Cancer Survivorship Data Portal In St. Jude Cloud Launched At ASHG

(St. Jude Children’s) Oct 18, 2019 - A St. Jude Children’s Research Hospital online portal into pediatric cancer survivorship data debuts at the American Society of Human Genetics annual meeting.